Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Ginkgo Bioworks Holdings, Inc. Class A Common Stock (NY:DNA)

13.91 +0.66 (+4.96%)
Streaming Delayed Price Updated: 10:14 AM EDT, Oct 20, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Ginkgo Bioworks Holdings, Inc. Class A Common Stock

< Previous 1 2 3 4 5 6 7 8 9
...
13 14 Next >
2 Growth Stocks That Could Double Your Money, According to Wall Street
Find out why investment bank analysts are pounding the table on these stocks. 
Via The Motley Fool
2 Exciting Biotech Stocks to Buy With Less Than $10
You can pick up these stocks for a song right now. 
Via The Motley Fool
Cathie Wood Goes Shopping For Stock of Jack Dorsey's Block — Ark Invest Bolsters Portfolio With Archer Aviation, CRISPR Shares
 
Via Benzinga
3 Biotech Stocks Ready to Break Out in 2024
These top three biotech companies are ready to roar into the new year with promising new trials, drugs, and innovative use of AI. 
Via InvestorPlace
Cathie Wood's Ark Invest Sells Over $25M Worth Of Tesla Shares Amid Boost In Price
 
Via Benzinga
3 Promising Cathie Wood Stocks That Will Make Early Investors Rich
Although the innovation space is getting squirrelly, these Cathie Wood stocks to make you rich provide compelling narratives. 
Via InvestorPlace
2 Magnificent Growth Stocks to Buy Right Now
These two biotech stocks could be big winners for patient investors. 
Via The Motley Fool
Wall Street Says Ginkgo Bioworks Stock Will Soar 132%, and Cathie Wood's Buying It. Should You?
It's not a stock for the faint of heart, but its ambitious vision might pay off. 
Via The Motley Fool
3 Stocks Wall Street Thinks Can Nearly Double -- and Why They Might Be Dead Wrong
Investors should be careful with these stocks, because their potential may not be as promising as their price targets suggest they are. 
Via The Motley Fool
3 Healthcare Stocks to Keep an Eye On
These three lesser-known healthcare companies have strong growth potential. 
Via The Motley Fool
Why Ginkgo Bioworks Stock Is Surging Higher Today
A new collaboration with Pfizer is fueling a rally in the company's shares today. 
Via The Motley Fool
MillerKnoll, Hayward Holdings, Ginkgo Bioworks And Other Big Stocks Moving Higher On Wednesday
U.S. stocks traded mostly higher, with the Nasdaq Composite gaining around 40 points on Wednesday. Here are some big stocks recording gains in today’s session. 
Via Benzinga
Topics Stocks
MMAT Stock Alert: The $6.2 Million Reason Meta Materials Is Up Today
Meta Materials stock is getting a boost on Wednesday as investors in MMAT react positively to $6.2 million in new product orders. 
Via InvestorPlace
These 2 Stocks Are Getting Smart Investors' Attention Wednesday
Big movers in either direction can give hints about broader market sentiment. 
Via The Motley Fool
Pfizer Is Sending Ginkgo Bioworks (DNA) Stock Higher: Here's Why
Ginkgo Bioworks Holdings Inc (NYSE: DNA) shares are trading higher Wednesday after the company announced a collaboration with Pfizer Inc (NYSE: PFE) focused on the 
Via Benzinga
DNA Stock Alert: Ginkgo Bioworks Announces Major Partnership With Pfizer
The deal keeps Ginkgo alive, but its business model of becoming the "Apple Store of Biotech" remains unproven. DNA stock jumped overnight. 
Via InvestorPlace
Cathie Wood’s Stock Shuffle: 4 Names She’s Loving, 3 She’s Leaving
Investors tend to closely watch which Cathie Wood stocks are bought and sold as she has history of generating big returns in her ETFs 
Via InvestorPlace
2 Beaten-Down Growth Stocks That Could Rocket 107% to 127% Higher, According to Wall Street
These stocks have taken a tumble, but the investment bank analysts who follow them still think they can produce eye-popping returns. 
Via The Motley Fool
These 2 Growth Stocks Are Down More Than 20%, but Billionaires Are Buying Them Hand Over Fist
Some of the world's most successful investors are buying millions of shares of these growth stocks. 
Via The Motley Fool
Immunomics Stocks: 3 Ways to Play This Massive AI-Biotech Megatrend
Ginkgo Bioworks, Recursion Pharmaceutical, and Eli Lilly are cashing in on the AI-Biotech trend of tomorrow using the big data of today. 
Via InvestorPlace
Cathie Wood Goes Bargain Hunting: 3 Stocks She Just Bought
The widely followed growth investor keeps adding to some of her top holdings. 
Via The Motley Fool
Cathie Wood's Ark Invest Sells Tesla Shares Worth $15.9M, Bolsters Positions In Palantir By $14.9M
 
Via Benzinga
Cathie Wood's Ark Offloads Tesla Shares Worth $8.4M While Staying Bullish On Elon Musk's EV Company
 
Via Benzinga
Ginkgo Bioworks is Teaming Up With Alphabet For AI, But Does That Make It a Buy?
The move is unsurprising, but it will be positive for shareholders. 
Via The Motley Fool
Topics Artificial Intelligence
Cathie Wood Continues To Trim Its Tesla Holdings Amid Stock Rally — Ark Invest Sells $20.56M Worth Of Shares
 
Via Benzinga
The 7 Most Undervalued Cathie Wood Stocks to Buy in September 2023
Elevate your portfolio with these Cathie Wood's undervalued stocks brimming with robust long-term growth potential 
Via InvestorPlace
Cathie Wood Is Buying These 2 Biotech Stocks Hand Over Fist, and Wall Street Thinks They Could Double
These businesses could be on the verge of takeoff. 
Via The Motley Fool
Why Ginkgo Bioworks Stock Was a 34% Winner This Week
In one of two recently announced deals, the company has found a powerful partner to help it with its artificial intelligence (AI) efforts. 
Via The Motley Fool
Topics Artificial Intelligence
Why Did This Cathie Wood Stock Soar 24% on Tuesday?
Ginkgo Bioworks stock soars on Google Cloud Partnership announcement. Is this a thesis changer? 
Via The Motley Fool
What's Going On With Ginkgo Bioworks Stock?
Ginkgo Bioworks Holdings Inc (NYSE: DNA) shares are on the move again Wednesday. 
Via Benzinga
< Previous 1 2 3 4 5 6 7 8 9
...
13 14 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.